Rivaroxaban-Mepha 20 mg, Filmtabletten - 98 Swissmedic Key 68439010 Registration Holder Mepha Pharma AG Name Rivaroxaban-Mepha 20 mg, Filmtabletten Date of registration 15.03.2022 Original/Generic Generic Introduction of Sequence 15.03.2022 ATC-Classification (Codice) Revision date WHO Valid until 14.03.2027 Index Therapeuticus (BSV) 06.03.40. Show package size 98 Index Therapeuticus (Swissmedic) 06.03. Description Swissmedic categorie. B SL Eintrag Yes Indication Information for professionals IP Consumer information Ex-factory-Price 69.13 Limitation No Deductible 10 % Consumer price 91.60 Feedback FB GTIN 7680684390104 Medication Code Synthetika Pharmacode Disponibility
Composition rivaroxabanum 20 mg, natrii laurilsulfas, lactosum monohydricum 167.2 mg, hypromellosum, carmellosum natricum conexum, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum 3350, talcum, E 172 (rubrum), pro compresso obducto corresp. natrium max. 1.19 mg. Packungsbestandteile Galenic Form Coated tablets Active Agent Dose Rivaroxabanum 20 mg
BAG: Active Agent Dose Rivaroxabanum 20 mg
Inactive agents Dose additional_information (Rubrum) Carmellosum Natricum Conexum E 172 color. Hypromellosum Lactose Monohydrate 167.2 mg Macrogol 3350 Magnesii Stearas Natrii Laurilsulfas Poly(Alcohol Vinylicus) Überzug Pro Compresso Obducto Talcum
Source Data was imported : 06.04.2022
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :